Glycosylation Modulates Plasma Membrane Trafficking of CD24 in Breast Cancer Cells

Int J Mol Sci. 2021 Jul 29;22(15):8165. doi: 10.3390/ijms22158165.

Abstract

In breast cancer, expression of Cluster of Differentiation 24 (CD24), a small GPI-anchored glycoprotein at the cell periphery, is associated with metastasis and immune escape, while its absence is associated with tumor-initiating capacity. Since the mechanism of CD24 sorting is unknown, we investigated the role of glycosylation in the subcellular localization of CD24. Expression and localization of wild type N36- and/or N52-mutated CD24 were analyzed using immunofluorescence in luminal (MCF-7) and basal B (MDA-MB-231 and Hs578T) breast cancer cells lines, as well as HEK293T cells. Endogenous and exogenously expressed wild type and mutated CD24 were found localized at the plasma membrane and the cytoplasm, but not the nucleoplasm. The cell lines showed different kinetics for the sorting of CD24 through the secretory/endocytic pathway. N-glycosylation, especially at N52, and its processing in the Golgi were critical for the sorting and expression of CD24 at the plasma membrane of HEK293T and basal B type cells, but not of MCF-7 cells. In conclusion, our study highlights the contribution of N-glycosylation for the subcellular localization of CD24. Aberrant N-glycosylation at N52 of CD24 could account for the lack of CD24 expression at the cell surface of basal B breast cancer cells.

Keywords: CD24; breast cancer; endocytic sorting; glycosylation; luminal and basal B cell lines.

MeSH terms

  • Breast Neoplasms / metabolism*
  • CD24 Antigen / metabolism*
  • Cell Line, Tumor
  • Cell Membrane / metabolism*
  • Female
  • Glycosylation
  • Humans

Substances

  • CD24 Antigen
  • CD24 protein, human